Sichenzia Ross Friedman Ference LLP Represents Rodman & Renshaw in Public Offering of Skystar Bio-Pharmaceutical
NEW YORK, NY -- (Marketwire) -- 07/07/09 -- Sichenzia Ross Friedman Ference LLP, a leading securities law firm specializing in micro, small and mid-cap public companies, today announced their successful representation of Rodman & Renshaw, LLC in an underwritten public offering of Skystar Bio-Ph...

Skystar Bio-Pharmaceutical Announces Exercise of Over-Allotment Purchase Option
XI'AN, CHINA -- (Marketwire) -- 07/01/09 -- Skystar Bio-Pharmaceutical Co., Ltd. (NASDAQ: SKBI), a China-based producer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced that Rodman & Renshaw, LLC exercised the over-allotment option to purcha...

Skystar Bio-Pharmaceutical Announces Pricing of Public Offering of Common Stock
XI'AN, CHINA -- (Marketwire) -- 06/30/09 -- Skystar Bio-Pharmaceutical Co., Ltd. (NASDAQ: SKBI), a China-based producer and distributor of veterinary medicines, vaccines, micro-organisms and feed additives, today announced that it has priced its public offering of 1,400,000 shares of common stock. ...

Skystar Bio-Pharmaceutical Begins Trading on NASDAQ Capital Market
XI'AN, CHINA -- (Marketwire) -- 06/26/09 -- Skystar Bio-Pharmaceutical Co., Ltd. (NASDAQ: SKBI) ("Skystar"), a leading China-based producer and distributor of veterinary medicines, vaccines, microorganisms and feed additives, announced that its common stock will begin trading on the NASDAQ Capital ...

Skystar Bio-Pharmaceutical Reports First Quarter 2009 Financial Results
XI'AN, CHINA -- (Marketwire) -- 05/20/09 -- Skystar Bio-Pharmaceutical (OTCBB: SKBO) ("Skystar"), a leading developer and distributor of veterinary healthcare and medical care products in the People's Republic of China ("PRC"), today reported its financial results for the year ended March 31, 200...